Measurement of tobramycin and gentamicin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis

J Cyst Fibros. 2005 Sep;4(3):209. doi: 10.1016/j.jcf.2005.05.016.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / pharmacokinetics*
  • Child
  • Cystic Fibrosis / drug therapy
  • Cystic Fibrosis / metabolism*
  • Drug Monitoring
  • Gentamicins / pharmacokinetics*
  • Humans
  • Immunoassay
  • Saliva / metabolism*
  • Tobramycin / pharmacokinetics*

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Tobramycin